Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression.

Stahl SM, Entsuah R, Rudolph RL.

Biol Psychiatry. 2002 Dec 15;52(12):1166-74.

PMID:
12488062
2.

Venlafaxine extended-release: a review of its use in the management of major depression.

Wellington K, Perry CM.

CNS Drugs. 2001;15(8):643-69. Review.

PMID:
11524036
4.

Mirtazapine versus selective serotonin reuptake inhibitors.

Thompson C.

J Clin Psychiatry. 1999;60 Suppl 17:18-22; discussion 46-8. Review.

5.
6.

Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis.

Smith D, Dempster C, Glanville J, Freemantle N, Anderson I.

Br J Psychiatry. 2002 May;180:396-404. Review.

PMID:
11983635
7.

Treatment of depression in the elderly: a review of the recent literature on the efficacy of single- versus dual-action antidepressants.

Mukai Y, Tampi RR.

Clin Ther. 2009 May;31(5):945-61. doi: 10.1016/j.clinthera.2009.05.016. Review.

PMID:
19539096
8.
9.

Clinical evaluation of venlafaxine.

Ballenger JC.

J Clin Psychopharmacol. 1996 Jun;16(3 Suppl 2):29S-35S; discussion 35S-36S. Review.

PMID:
8784646
10.

Milnacipran and selective serotonin reuptake inhibitors in major depression.

Lopez-Ibor J, Guelfi JD, Pletan Y, Tournoux A, Prost JF.

Int Clin Psychopharmacol. 1996 Sep;11 Suppl 4:41-6. Review.

PMID:
8923126
11.

Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.

Banzi R, Cusi C, Randazzo C, Sterzi R, Tedesco D, Moja L.

Cochrane Database Syst Rev. 2015 May 1;(5):CD011681. doi: 10.1002/14651858.CD011681. Review.

PMID:
25931277
12.

The patient with comorbid depression and anxiety: the unmet need.

Bakish D.

J Clin Psychiatry. 1999;60 Suppl 6:20-4. Review.

13.

Venlafaxine extended release (XR) in the treatment of generalized anxiety disorder.

Sheehan DV.

J Clin Psychiatry. 1999;60 Suppl 22:23-8. Review.

15.

Care of depressed patients with anxiety symptoms.

Nutt DJ.

J Clin Psychiatry. 1999;60 Suppl 17:23-7; discussion 46-8. Review.

16.

[Therapeutic action lag time and resistance to treatment].

Peretti CS.

Encephale. 1999 Jun;25 Spec No 2:49-54. Review. French.

PMID:
10434159
17.

The pharmacoeconomics of venlafaxine in depression.

Morrow TJ.

Am J Manag Care. 2001 Sep;7(11 Suppl):S386-92. Review.

18.

The use of newer antidepressants for panic disorder.

Gorman JM.

J Clin Psychiatry. 1997;58 Suppl 14:54-8; discussion 59. Review.

PMID:
9418747
19.

Treatment of major depression: is improvement enough?

Ferrier IN.

J Clin Psychiatry. 1999;60 Suppl 6:10-4. Review.

20.

Rapid onset of action of venlafaxine.

Montgomery SA.

Int Clin Psychopharmacol. 1995 Mar;10 Suppl 2:21-7. Review.

PMID:
7622814

Supplemental Content

Support Center